drugset

drugset / Trial / NCT00591396

A Phase I Trial of ZIO-101 in Solid Tumors

NCT00591396 ↗

Phase 1 Completed 40 enrolled Alaunos Therapeutics

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A Phase I Trial of ZIO-101 (Darinaparsin) in Solid Tumors

Timeline

Start: 2005-07
Primary completion: 2008-07
Completion: 2008-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Darinaparsin	Small molecule	—	—

Indications